BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12671950)

  • 1. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
    Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report.
    Wilkins A; Brown JM; Barker RA
    Mov Disord; 2004 May; 19(5):593-5. PubMed ID: 15133829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
    Charles P; Camuzat A; Benammar N; Sellal F; Destée A; Bonnet AM; Lesage S; Le Ber I; Stevanin G; Dürr A; Brice A;
    Neurology; 2007 Nov; 69(21):1970-5. PubMed ID: 17568014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The parkinsonian phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Kuo PC; Chang HC; Weng YH
    Arch Neurol; 2004 Jan; 61(1):35-8. PubMed ID: 14732617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex phenotypes in an Indian family with homozygous SCA2 mutations.
    Ragothaman M; Sarangmath N; Chaudhary S; Khare V; Mittal U; Sharma S; Komatireddy S; Chakrabarti S; Mukerji M; Juyal RC; Thelma BK; Muthane UB
    Ann Neurol; 2004 Jan; 55(1):130-3. PubMed ID: 14705123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
    Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
    Tan EK; Tong J; Pavanni R; Wong MC; Zhao Y
    Mov Disord; 2007 Oct; 22(13):1971-4. PubMed ID: 17712857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in familial Parkinson's disease with anticipation.
    Schraen-Maschke S; Brique S; Chartier-Harlin MC; Brique E; Destée A; Sablonnière B
    Am J Med Genet; 1999 Dec; 88(6):738-41. PubMed ID: 10581499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
    Infante J; Berciano J; Volpini V; Corral J; Polo JM; Pascual J; Combarros O
    Mov Disord; 2004 Jul; 19(7):848-852. PubMed ID: 15254952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation.
    Markopoulou K; Wszolek ZK; Pfeiffer RF
    Ann Neurol; 1995 Sep; 38(3):373-8. PubMed ID: 7668822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications.
    Shan DE; Liu RS; Sun CM; Lee SJ; Liao KK; Soong BW
    Mov Disord; 2004 Nov; 19(11):1357-60. PubMed ID: 15378681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism.
    Shan DE; Soong BW; Sun CM; Lee SJ; Liao KK; Liu RS
    Ann Neurol; 2001 Dec; 50(6):812-5. PubMed ID: 11761482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brisk deep-tendon reflexes as a distinctive phenotype in an Argentinean spinocerebellar ataxia type 2 pedigree.
    Rosa AL; Molina I; Kowaljow V; Conde CB
    Mov Disord; 2006 Jan; 21(1):66-8. PubMed ID: 16108012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
    Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
    Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Yen TC; Tsai CH; Chen RS; Chang HC
    Mov Disord; 2002 Sep; 17(5):1046-51. PubMed ID: 12360557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia.
    Worth PF; Houlden H; Giunti P; Davis MB; Wood NW
    Nat Genet; 2000 Mar; 24(3):214-5. PubMed ID: 10700168
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions.
    Socal MP; Emmel VE; Rieder CR; Hilbig A; Saraiva-Pereira ML; Jardim LB
    Parkinsonism Relat Disord; 2009 Jun; 15(5):374-8. PubMed ID: 18990604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.
    Zappia M; Annesi G; Nicoletti G; Arabia G; Annesi F; Messina D; Pugliese P; Spadafora P; Tarantino P; Carrideo S; Civitelli D; De Marco EV; Cirò-Candiano IC; Gambardella A; Quattrone A
    Arch Neurol; 2005 Apr; 62(4):601-5. PubMed ID: 15824260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.